Linde Stock Earnings Reports

Linde delivered a solid Q1 2026 despite a challenging geopolitical and macro backdrop. Key financials: EPS of $4.33 (+10% YoY), sales of $8.8 billion (+8% YoY, underlying +3%), operating margin 30%, operating cash flow $2.2 billion, CapEx $1.3 billion, free cash flow ~$900 million. Underlying sales growth was driven by pricing (+2%) and modest volume (+1%), with FX a ~5% tailwind. End-market performance was mixed: healthcare resilient but affected in the U.S. home care segment by a policy change; food & beverage and electronics (chips/AI-related) were strong (electronics +10%); chemicals & energy and metals/mining showed regional divergence (strength in Americas and APAC, weakness in EMEA). Helium market tightened rapidly after prior oversupply; Linde is largely contracted (85–90%) and will prioritize meeting contracts and signing multiyear deals rather than spot sales. Project backlog (sale-of-gas) ended Q1 at $7.1 billion, with >$1 billion of ultra‑high‑purity electronics investments underway and further large electronics projects expected to be added. Capital allocation remains balanced: dividend increased 7% (33rd consecutive year of increases) and ~$800 million of buybacks in the quarter while reinvesting ~$1.5 billion. Updated guidance: Q2 EPS $4.40–$4.50 (8–10% growth); full-year EPS $17.60–$17.90 (7–9% growth), including ~1% FX tailwind; bottom of range raised $0.20 vs prior guidance. Management remains cautiously optimistic on margin expansion for 2026 but is guarded given geopolitical uncertainty. Risks include continued EMEA weakness, project timing shifts (e.g., Wood project slip), and evolving helium supply dynamics that could create upside or additional volatility.